The summary below gives an overview of important additions and changes MPR has made to its drug database through the end of June. The chart below provides highlights of key monograph updates made this month (not an inclusive list).
Click on the name of the drugs to view the full monographs on eMPR.com.
Key: D=Dosing, IND=Indication, ITX=Interactions, CI=Contraindications,
W/P=Warnings/Precautions, ADR=Adverse Reactions,
HS=How Supplied, MFR=Manufacturer Change
| DRUG NAME | UPDATES | |||||||
| (Click on drug name to go to MPR monograph.) | IND | D | CON | W/P | ITX | ADR | HS | MFR |
| AYVAKIT (Avapritinib) |
X | X | X | X | ||||
| BACTRIM (Sulfamethoxazole, trimethoprim) |
X | X | X | |||||
| COSENTYX (Secukinumab) |
X | X | X | |||||
| HIZENTRA (Immune globulin [human]) |
X | X | X | |||||
| INFED (Iron [as dextran complex]) | X | X | X | |||||
| LYMPHOSEEK (Technetium Tc 99m tilmanocept) | X | X | X | |||||
| NURTEC ODT (Rimegepant) |
X | X | X | |||||
| YERVOY (Ipilimumab) |
X | X | X | |||||
| ZEPOSIA (Ozanimod) |
X | X |
X | X | X | |||
| ZIPSOR (Diclofenac potassium) |
X | X | X | X | ||||
| Review more drug monograph updates |
